[Soluble-phase adhesion molecules as biohumoral markers of vascular activation in vivo].
Gianetti
J
J
Istituto di Fisiologia Clinica del CNR, Scuola Superiore di Studi Universitari e di Perfezionamento, Pisa.
Vaghetti
M
M
Petronio
S
S
Mariani
M
M
De Caterina
R
R
D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000097:blood* / Q000209:etiology; D015815:Cell Adhesion Molecules / Q000097:blood / Q000502:physiology; D003920:Diabetes Mellitus / Q000097:blood / Q000209:etiology; D004730:Endothelium, Vascular / Q000166:cytology* / Q000502:physiology; D005260:Female; D006084:Graft Rejection; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood; D007136:Immunoglobulins / Q000097:blood / Q000502:physiology; D007249:Inflammation / Q000097:blood / Q000209:etiology; D016023:Integrins / Q000097:blood / Q000502:physiology; D008297:Male; D008833:Microcirculation; D015999:Multivariate Analysis; D012307:Risk Factors; D019087:Selectins / Q000097:blood / Q000502:physiology; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood / Q000502:physiology
D015415:Biomarkers; D015815:Cell Adhesion Molecules; D007136:Immunoglobulins; D016023:Integrins; D019087:Selectins; D019010:Vascular Cell Adhesion Molecule-1